Shares Of Granules India Gained 2 Percent In The Early Trade On Tuesday

Shares of Granules India gained 2 percent in the early trade on Tuesday as the company received a US FDA nod for Methocarbamol tablets.

The US Food & Drug Administration approved the abbreviated new drug application filed by company for Methocarbamol tablet 500 mg and 750 mg.

The approved ANDA is the bioequivalent and therapeutically equivalent to reference listed drug of Robaxin 500 mg and 750 mg of Auxilium Pharmaceuticals, LLC.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory